Replies to post #421865 on NorthWest Biotherapeutics Inc (NWBO)

[Smokey21]

As someone else said here, the publication, by dozens of leading Neurosurgeons will lend much more credibility to the results than just the company publishing it and trying to explain why they changed endpoints for the trial in the new SAP. That process takes time and is out of their control, so giving any guidance other than what they already have given would likely work against them. I think keeping things vague at this point in time is probably best for all, since any timeline given will likely be used against them. The shorts don't know if it will be Monday, or Next year at this point, so they better be careful. And for those of us that are long, well, we know sooner or later, or position will be vindicated, or we will be the fools. I believe strongly it will be the first of those two.

[IkeEsq]

RE: DavidW2

I wish I knew. I can guess but my guesses are not based on a lot of knowledge in the area of biotech, clinical trials, or regulatory agencies. A little over a year ago I surmised that they were going to wait on a Journal publication (https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159422319). Maybe I was prescient then, or lucky, or completely full of . . . something. ONly time will tell.

There are lots of reasons to delay and to be silent and some are good while others are bad. Looking at the other indicators, it looks very much to me that it is at least good and maybe much more than that. But we can only guess because if we really knew, then we would not be selling at < $1. So we wait. Patiently.